MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Understanding Social Isolation before, during and after the Covid-19 pandemic among Patients with Parkinson’s disease

    A. Mehta, S. Ng, N. Chia, X. Choi, D. Heng, S. Neo, Z. Xu, K. Tay, W. Au, E. Tan, L. Tan (Singapore, Singapore)

    Objective: The aim of this study was to understand and measure the effect of social network support in patients with Parkinson’s disease(PwP) before, during and…
  • 2023 International Congress

    Pharmacological Invivo and invitro potential of resveratrol in experimental rat models of Parkinson’s disease

    R. Kumar, A. Kanojia (Darbhanga, India)

    Objective: Aim of study was to elucidate the pharmacological Invivo and invitro effects and mechanisms of action ofRT in experimental models of PD. Background: The…
  • 2023 International Congress

    A systematic review of Action Observation Therapy for Parkinson’s disease rehabilitation.

    A. Ibrahim Abdelhamed, H. Samy, M. Elafifi, R. Hesham, M. Walid, M. Salah, M. Mohamed, R. Fekry, S. Elwaly, M. Zakzok, M. Fahmy Mohamed, M. Agaiby Amin, A. Melad Sedarous, M. Shafiek Saleh (Elfashn, Egypt)

    Objective: This systematic review summarizes all published outcomes of Parkinson’s patients treated with AOT. Background: Gait disorders in patients with Parkinson’s disease (PD) are caused…
  • 2023 International Congress

    Potential treatment for CMT2S caused by IGHMBP2 cryptic splice variant, with ASO based therapeutic

    S. Smieszek, C. Tyner, A. Kaden, C. Johnson, C. Polymeropoulos, G. Birznieks, M. Polymeropoulos (Washington, USA)

    Objective: Our objective was to target a specific cryptic splice site variant affecting immunoglobulin mu‐binding protein 2 (IGHMBP2) protein levels with a novel antisense oligonucleotide…
  • 2023 International Congress

    Ethnic and Gender Disparities in Access to Deep Brain Stimulation for Parkinson’s Disease Among Participants in C-OPN

    I. Ojo, S. Poonja, J. Miyasaki, A. Shetty, T. Sankar, F. Ba (Edmonton, Canada)

    Objective: To study the disparities in gender and ethnicity and the related contributing factors in Parkinson’s disease (PD) patients who require deep brain stimulation (DBS),…
  • 2023 International Congress

    Istradefylline effect on Parkinson’s Disease Tremor, Motor symptoms and non-Motor symptoms.

    K. Chandrakumar, B. Wilmarth, B. Nagle, G. Di Maria, O. Gonul, L. Lovelace, E. Waldon, K. Getchell, Y. Torres-Yaghi, F. Pagan (Washington, USA)

    Objective: Istradefylline is FDA approved for use in patients with PD treated with carbidopa-levodopa to reduce off time. GUH Movement Disorder Group has observed that…
  • 2023 International Congress

    The Value of Physician Assistant/Associates (PAs) in a Movement Disorder Clinic

    J. Karl, C. Cooper (Chicago, USA)

    Objective: To assess the value and productivity of physician assistants/associates (PA) in a movement disorder clinic. Background: Due to the aging population and shortage of…
  • 2023 International Congress

    Identification of pre-frailty in the elderly through serum metabolomics and its impact on Parkinson’s disease phenotype

    A. Imarisio, M. Avenali, G. Buongarzone, M. Picascia, T. Nuzzo, C. Gasparri, F. Errico, C. Marino, M. Grimaldi, MC. Monti, A. Filosa, M. Rondanelli, C. Pacchetti, AM. D'Ursi, A. Usiello, EM. Valente (Pavia, Italy)

    Objective: We attempted to better characterize pre-frailty using serum metabolomics in a large cohort of elderly subjects without neurodegenerative diseases. Next, we sought to investigate…
  • 2023 International Congress

    Association of vestibular disorders with autonomic dysfunction in Parkinson’s Disease

    O. Alenikova, M. Leshkovich (Minsk, Belarus)

    Objective: Investigation of changes in VOR and VCR parameters in PDpatients in relation to motor and autonomic disorders severity. Background: Vestibulo-ocular reflex (VOR) and vestibular-colic…
  • 2023 International Congress

    Intrarater and interrater reliability of the 3 meter backward walk test in individuals with Parkinson disease.

    A. Boddy, K. Barta, L. Perry, M. Flores, K. Sawyer, A. Campbell (St Augustine, USA)

    Objective: Determine the intrarater and interrater reliability of the three meter backward walk (3 MBW) test for individuals diagnosed with Parkinson Disease. Background: Background- Parkinson…
  • « Previous Page
  • 1
  • …
  • 272
  • 273
  • 274
  • 275
  • 276
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Safety and Tolerability of a Ketone Supplement in Parkinson's Disease
  • Successful external defibrillation in a patient with bilateral deep brain stimulation
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley